Bruceantin targets HSP90 to overcome resistance to hormone therapy in castration-resistant prostate cancer. | EBSCOhost

Connecting you to content on EBSCOhost

Title: Bruceantin targets HSP90 to overcome resistance to hormone therapy in castration-resistant prostate cancer.
Authors: Sue Jin Moon; Byong Chang Jeong; Hwa Jin Kim; Joung Eun Lim; Hye-Jeong Kim; Ghee Young Kwon; Jackman, Joshua A.; Jeong Hoon Kim
Publication: Theranostics, 2021, Vol 11, Issue 2, p958
ISSN: 1838-7640
Publication type: Academic Journal
DOI: 10.7150/thno.51478